ACHL NASDAQ
Achilles Therapeutics plc
1W: +2.8%
1M: +7.2%
3M: +53.4%
1Y: +14.7%
3Y: -52.9%
$1.48
Last traded 2025-03-24 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-64M
Net Income
+9.5% YoY
$-31M
Free Cash Flow
+30.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-44.3%
ROA-39.0%
ROIC-225.5%
Valuation
P/E-0.9
P/B0.4
EV/EBITDA0.9
Leverage
Debt/Equity0.04
Current Ratio8.24
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z-2.66
Beneish M0.00